124 related articles for article (PubMed ID: 16858686)
41. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
42. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
43. Inactivation of tumor suppressor genes p15(INK4b) and p16(INK4a) in primary cutaneous B cell lymphoma.
Child FJ; Scarisbrick JJ; Calonje E; Orchard G; Russell-Jones R; Whittaker SJ
J Invest Dermatol; 2002 Jun; 118(6):941-8. PubMed ID: 12060387
[TBL] [Abstract][Full Text] [Related]
44. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
45. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas.
Peng DF; Kanai Y; Sawada M; Ushijima S; Hiraoka N; Kitazawa S; Hirohashi S
Carcinogenesis; 2006 Jun; 27(6):1160-8. PubMed ID: 16537562
[TBL] [Abstract][Full Text] [Related]
46. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma.
Fujiwara-Igarashi A; Goto-Koshino Y; Sato M; Maeda S; Igarashi H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2014 Feb; 199(2):236-44. PubMed ID: 24365070
[TBL] [Abstract][Full Text] [Related]
48. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
Phé V; Cussenot O; Rouprêt M
BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
[TBL] [Abstract][Full Text] [Related]
49. Methylation analysis of the cell cycle control genes in myelofibrosis with myeloid metaplasia.
Kumagai T; Tefferi A; Jones L; Koeffler HP
Leuk Res; 2005 May; 29(5):511-5. PubMed ID: 15755503
[TBL] [Abstract][Full Text] [Related]
50. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
51. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
[TBL] [Abstract][Full Text] [Related]
52. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
53. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
[TBL] [Abstract][Full Text] [Related]
54. Array-based DNA methylation profiling of primary lymphomas of the central nervous system.
Richter J; Ammerpohl O; Martín-Subero JI; Montesinos-Rongen M; Bibikova M; Wickham-Garcia E; Wiestler OD; Deckert M; Siebert R
BMC Cancer; 2009 Dec; 9():455. PubMed ID: 20025734
[TBL] [Abstract][Full Text] [Related]
55. Aberrant CpG island methylation of multiple genes in ependymal tumors.
Alonso ME; Bello MJ; Gonzalez-Gomez P; Arjona D; de Campos JM; Gutierrez M; Rey JA
J Neurooncol; 2004; 67(1-2):159-65. PubMed ID: 15072463
[TBL] [Abstract][Full Text] [Related]
56. DNA methylation profiles of lymphoid and hematopoietic malignancies.
Takahashi T; Shivapurkar N; Reddy J; Shigematsu H; Miyajima K; Suzuki M; Toyooka S; Zöchbauer-Müller S; Drach J; Parikh G; Zheng Y; Feng Z; Kroft SH; Timmons C; McKenna RW; Gazdar AF
Clin Cancer Res; 2004 May; 10(9):2928-35. PubMed ID: 15131027
[TBL] [Abstract][Full Text] [Related]
57. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL.
Cobbers JM; Wolter M; Reifenberger J; Ring GU; Jessen F; An HX; Niederacher D; Schmidt EE; Ichimura K; Floeth F; Kirsch L; Borchard F; Louis DN; Collins VP; Reifenberger G
Brain Pathol; 1998 Apr; 8(2):263-76. PubMed ID: 9546285
[TBL] [Abstract][Full Text] [Related]
58. Emerging insights into origin and pathobiology of primary central nervous system lymphoma.
You H; Wei L; Kaminska B
Cancer Lett; 2021 Jul; 509():121-129. PubMed ID: 33766752
[TBL] [Abstract][Full Text] [Related]
59. Characterization of genomic alterations in primary central nervous system lymphomas.
Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
[TBL] [Abstract][Full Text] [Related]
60. DNA methylation of multiple genes in vestibular schwannoma: Relationship with clinical and radiological findings.
Lassaletta L; Bello MJ; Del Río L; Alfonso C; Roda JM; Rey JA; Gavilan J
Otol Neurotol; 2006 Dec; 27(8):1180-5. PubMed ID: 16983315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]